Court Opinion

ID: 6338115
Source: CourtListenerOpinion
Date Created: 2022-05-05 16:12:03.26101+00
Date Added: 2024-06-11T09:23:57.971265
License: Public Domain

J-A05017-22

                                   2022 PA Super 82

    COMMONWEALTH OF PENNSYLVANIA               :   IN THE SUPERIOR COURT OF
                                               :        PENNSYLVANIA
                                               :
                v.                             :
                                               :
                                               :
    FRANKLIN ROOSEVELT DABNEY JR.              :
                                               :
                       Appellant               :   No. 638 MDA 2021

          Appeal from the Judgment of Sentence Entered May 4, 2021,
                in the Court of Common Pleas of Adams County,
             Criminal Division at No(s): CP-01-CR-0001083-2020.

BEFORE:      OLSON, J., KUNSELMAN, J., and STEVENS, P.J.E.*

OPINION BY KUNSELMAN, J.:                                  FILED MAY 05, 2022

        Franklin Roosevelt Dabney, Jr. appeals from the judgment of sentence

imposed following his convictions for driving under the influence (DUI) of a

Schedule I controlled substance, DUI of a Schedule I controlled substance

metabolite, DUI of a drug (actual impairment), careless driving, and maximum

speed limits.1 Dabney challenges, first, the denial of his petition for writ of

habeas corpus wherein he argued that medical marijuana is not a Schedule I

controlled substance for purposes of Section 3802(d)(1)(i) and (iii) and,

second, the denial of his motion to suppress the results of the blood draw

taken after his arrest for suspicion of DUI. We affirm.

        The suppression court found the following facts:

____________________________________________

*   Former Justice specially assigned to the Superior Court.

1 75 Pa.C.S.A. §§ 3802(d)(1)(i), 3802(d)(1)(iii), 3802(d)(2), 3714(a), and
3362(a)(3).
J-A05017-22

       1. Trooper Mark Brandt is an employee with the Pennsylvania
       State Police and has been a Trooper for 5 years.

       2. In his career, Trooper Brandt has been involved in
       approximately 100 DUI investigations; approximately 50% of the
       investigations involved individuals suspected of driving under the
       influence of a controlled substance with 35%–40% involving
       marijuana. Trooper Brandt is familiar with the odor of raw and
       burnt marijuana.

       3. As part of Trooper Brandt’s training he was instructed in the
       Standardized Field Sobriety Test (SFST) and Advanced Roadside
       Impaired Driving Enforcement (ARIDE) training. ARIDE deals
       specifically with individuals suspected to be under the influence of
       controlled substances.

       4. On April 27, 2020, Trooper Brandt was stationary on Route 15
       in Tyrone Township, Adams County, Pennsylvania, in full uniform
       and in an unmarked police vehicle conducting radar and clocked a
       blue Hyundai Sonata traveling 93 miles per hour in a 65 mile per
       hour zone.[2]

       5. Trooper Brandt conducted a traffic stop of the Hyundai Sonata
       in Tyrone Township. [Dabney] was driving the vehicle and there
       was a front and back seat passenger in the vehicle.

       6. Other than speeding, trooper Brandt did not observe any other
       erratic driving and [Dabney] safely stopped his vehicle.

       7. Trooper Brandt was wearing a disposable mask for Covid-19
       precaution and detected the faint odor of raw marijuana as he
       approached [Dabney’s] vehicle.

       8. Upon request from Trooper Brandt, [Dabney] properly provided
       all documents and information.

       9. Trooper Brandt returned to his police vehicle and prepared a
       citation for speeding. Trooper Brandt reapproached the vehicle
       and had contact with [Dabney] while [Dabney] was seated in the
       driver’s seat. While speaking with [Dabney], Trooper Brandt
       noticed a strong odor of raw marijuana coming from inside the
       vehicle.    [Dabney] denied having marijuana in the vehicle.
____________________________________________

2 Trooper Brandt first testified that the speed was 92 miles per hour, N.T.,
12/14/20, at 13–14, then that it was 93 miles per hour, id. at 23. The above
factual finding is supported by the record, so we will not disturb it.

                                           -2-
J-A05017-22

       [Dabney] produced a medical marijuana card and related the odor
       of marijuana is probably from his clothes.

       10. Trooper Brandt directed [Dabney] and the two passengers to
       exit the vehicle. Trooper Brandt and Trooper [Clay] Forcey
       conducted a warrantless probable cause search of [Dabney’s]
       vehicle. Trooper Brandt observed flakes of suspected marijuana
       around the center console and front passenger seat. Trooper
       Forcey located a white plastic shopping bag containing three
       individually packaged clear plastic bags containing suspected
       marijuana in the vehicle’s trunk.

       11. While interacting with [Dabney], Trooper Brandt observed that
       [Dabney’s] eyes were dilated and red.

       12. Trooper Brandt requested SFST tests and [Dabney] agreed.
       Trooper Brandt conducted the [Horizontal Gaze Nystagmus
       (HGN)] test, walk and turn test, and one leg stand test.

       13. During the walk and turn test Trooper Brandt observed
       [Dabney] raise his arms, stop briefly during the test, and not
       count correctly. These were all indicators that [Dabney] might be
       impaired.

       14. During the one leg stand test, Trooper Brandt observed
       [Dabney] improperly lift his leg, sway and improperly put his foot
       down, all indicators of impairment.

       15. Trooper Brandt also conducted two ARIDE tests, the lack of
       convergence test and the Romberg balance test. Trooper Brandt
       observed a lack of convergence with [Dabney’s] eyes,[3] observed
       eyelid tremors during the Romberg balance test and observed
       [Dabney] did not properly estimate the proper time period for the
       test, all indicators of impairment.

                                      *        *   *

       18. Trooper Brandt placed [Dabney] under arrest for suspected
       driving under the influence of a controlled substance. [Dabney]
       was transported to Gettysburg Hospital for a blood test.

____________________________________________

3Contrary to the suppression court’s findings, Trooper Brandt testified that he
did not observe any lack of convergence. N.T., 12/14/20, at 22.

                                           -3-
J-A05017-22

Trial Court Opinion, 1/29/21, at 2–3.            Dabney’s blood contained active

marijuana compounds and metabolites. In addition to the above offenses,

Dabney was charged at Counts 1, 2, and 3 with violation of the Medical

Marijuana Act, possession of marijuana, and possession of a small amount of

marijuana.4

        On November 9, 2020, Dabney filed an omnibus pre-trial motion to

suppress and petition for writ of habeas corpus. The suppression court heard

the matter on December 14, 2020, and the parties filed briefs on January 12

and 13, 2021. The Commonwealth agreed to the suppression of the marijuana

found in the vehicle.

        On January 29, 2021, the suppression court denied Dabney’s motion to

suppress based on Trooper Brandt’s lack of probable cause to arrest and the

petition for writ of habeas corpus. Based on the Commonwealth’s concession,

the suppression court granted Dabney’s motion to suppress the fruits of the

vehicle search. The Commonwealth withdrew Counts 1, 2, and 3.

        The case proceeded to a non-jury trial on May 4, 2021 based on a

stipulated record, where the court found Dabney guilty on all remaining

counts. The court sentenced Dabney the same day. Dabney timely appealed,

raising the following two issues for our review:

        1. Did the lower court err in determining that [Dabney’s] valid
           prescription for Medical Marijuana, and the legal ingestion

____________________________________________

4   35 P.S. §§ 10231.303(b)(6), 780-113(a)(16), and 780-113(a)(31)(i).

                                           -4-
J-A05017-22

          thereof, did not prevent prosecution under sections
          3802(d)(1)(i) and 3802(d)(1)(iii) of the Vehicle Code?

       2. Did the lower court err in determining that there was sufficient
          probable cause to arrest [Dabney] for driving Under the
          Influence and should have suppressed the subsequent blood
          draw of [Dabney]?

Dabney’s Brief at 4.

        I.    Medical Marijuana Is a Schedule I Controlled Substance.

       Dabney first argues that marijuana that is ingested pursuant to the

Medical Marijuana Act, 35 P.S. §§ 10231.101–10231.2110 (MMA), is not a

controlled substance within the meaning of the Controlled Substance, Drug,

Device and Cosmetic Act, 35 P.S. §§ 780-101–780-144 (CSA) (also called the

Drug Act), and therefore he could not be prosecuted for DUI under 75

Pa.C.S.A. § 3802(d)(1) based on medical marijuana in his blood.5

       Dabney’s issue is one of statutory interpretation. Our standard of review

is well-settled:

             Statutory interpretation is a question of law, therefore our
       standard of review is de novo, and our scope of review is plenary.
       Commonwealth v. Hall, 622 Pa. 396, 80 A.3d 1204, 1211
       (2013). “In all matters involving statutory interpretation, we
       apply the Statutory Construction Act, 1 Pa.C.S. § 1501 et seq.,
       which provides that the object of interpretation and construction
       of statutes is to ascertain and effectuate the intention of the
       General Assembly.” Commonwealth v. McCoy, 599 Pa. 599,
       962 A.2d 1160, 1166 (2009) (citation omitted).

             Generally, a statute’s plain language provides the best
       indication of legislative intent. Id. We will only look beyond the

____________________________________________

5In this first issue, Dabney does not challenge his prosecution under Section
3802(d)(2).

                                           -5-
J-A05017-22

       plain language of the statute when words are unclear or
       ambiguous, or the plain meaning would lead to “a result that is
       absurd, impossible of execution or unreasonable.” 1 Pa.C.S.
       § 1922(1).     Therefore, when ascertaining the meaning of a
       statute, if the language is clear, we give the words their plain and
       ordinary meaning. Hall, 80 A.3d at 1211.

Commonwealth v. Torres–Kuilan, 156 A.3d 1229, 1231 (Pa. Super. 2017)

(quoting Commonwealth v. Popielarcheck, 151 A.3d 1088, 1091–92 (Pa.

Super. 2016)).

       The Vehicle Code provides that

          [a]n individual may not drive, operate or be in actual
          physical control of the movement of a vehicle under any of
          the following circumstances:

          (1) There is in the individual’s blood any amount of a:

              (i)    Schedule I controlled substance, as defined in the
                    [CSA];

              (ii) Schedule II or Schedule III controlled substance, as
                  defined in [the CSA], which has not been medically
                  prescribed for the individual; or

              (iii) metabolite of a substance under subparagraph (i) or
                   (ii).

75 Pa.C.S.A. § 3802(d)(1).6 “The fact that a person charged with [DUI] is or

has been legally entitled to use alcohol or controlled substances is not a

defense to a charge of [DUI].” 75 Pa.C.S.A. § 3810.

____________________________________________

6 Under Section 3802(d)(1), proof of actual impairment is not required.
Commonwealth v. Etchison, 916 A.2d 1169, 1174 (Pa. Super. 2007),
distinguished on other grounds by Commonwealth v. Griffith, 32 A.3d 1231
(Pa. 2011).

                                           -6-
J-A05017-22

       The CSA defines schedules of controlled substances in relevant part as

follows:

       The following schedules include the controlled substances listed or
       to be listed by whatever official name, common or usual name,
       chemical name, or trade name designated.

       (1) Schedule I. In determining that a substance comes within this
       schedule, the secretary shall find: a high potential for abuse, no
       currently accepted medical use in the United States, and a lack of
       accepted safety for use under medical supervision. The following
       controlled substances are included in this schedule:

                                      *        *   *

              (iv) Marihuana.

35 P.S. § 780-104.7

       Prior to enactment of the MMA, we rejected a challenge to marijuana’s

classification as a Schedule I controlled substance based on its medical use in

the United States:

       [T]here is no requirement that the Schedule I substances listed
       under 35 P.S. § 780-104 continuously conform to the standard
       that there be “a high potential for abuse, no currently accepted
       medical use in the United States, and a lack of accepted safety for
       use under medical supervision.” 35 P.S. § 780-104(1). . . .
       Regardless of whether there are accepted medical uses for
       marijuana in the United States, marijuana remains a Schedule I
       substance under the Drug Act.

Commonwealth v. Waddell, 61 A.3d 196, 207 (Pa. Super. 2012).
____________________________________________

7 “Under the Drug Act, ‘marijuana’ is spelled: ‘marihuana.’ These words are
interchangeable, though ‘marijuana’ appears more frequently in conventional
usage. Either term refers to the genus of flowering plants known as Cannabis,
including the species Cannabis sativa, Cannabis indica, and Cannabis
ruderalis.” Commonwealth v. Waddell, 61 A.3d 196, 203 n.3 (Pa. Super.
2012).

                                           -7-
J-A05017-22

      The MMA was enacted effective May 17, 2016. Under the MMA, medical

marijuana is defined as marijuana for certified medical use as set forth in the

MMA. 35 P.S. § 10231.103. “Notwithstanding any provision of law to the

contrary, use or possession of medical marijuana as set forth in [the MMA] is

lawful within this Commonwealth.”      35 P.S. § 10231.303.     However, it is

unlawful to use medical marijuana except as provided in the MMA. 35 P.S.

§ 10231.304(a).   The MMA does not prevent civil or criminal penalties for

“[u]ndertaking any task under the influence of medical marijuana when doing

so would constitute negligence.” 35 P.S. § 10231.1309(1). Finally, the MMA

provides that it takes precedence over the CSA in areas of conflict:

      The growth, processing, manufacture, acquisition, transportation,
      sale, dispensing, distribution, possession and consumption of
      medical marijuana permitted under [the MMA] shall not be
      deemed to be a violation of the [CSA]. If a provision of the [CSA]
      relating to marijuana conflicts with a provision of [the MMA], [the
      MMA] shall take precedence.

35 P.S. § 10231.2101.

      After the MMA was enacted, we again considered statutory and

constitutional challenges to marijuana’s classification as a Schedule I

controlled substance. Commonwealth v. Jezzi, 208 A.3d 1105 (Pa. Super.

2019).   Jezzi asserted that because the General Assembly found that

marijuana was now accepted for its medical value, it no longer fit within the

definition of a Schedule I controlled substance.    Id. at 1109.    Relying on

Waddell and the text of the MMA, we rejected his statutory interpretation:

                                     -8-
J-A05017-22

      Initially, Appellant’s statutory “irreconcilable differences”
      argument lacks merit, where the MMA simply establishes a
      scheme for the lawful use of medical marijuana. See 35 P.S. §§
      10231.102(3), 10231.102(1) (stating scientific evidence suggests
      medical marijuana is one potential therapy that may have
      therapeutic benefits). The usage of language like “suggests,”
      “potential,” and “may” [in 35 P.S. § 10231.102(1), Declaration of
      policy,] does not conclusively demonstrate the General Assembly
      found marijuana to have accepted medical use other than for its
      palliative or analgesic effects. Rather, the statutory language
      illustrates the General Assembly’s intent to create legal avenues
      for research into the use of medical marijuana while providing
      pathways to potential relief for certain categories of patients. See
      id.

             Furthermore, the temporary nature of the MMA serves as an
      acknowledgement of the General Assembly that more research
      into the medical value of marijuana is necessary. See 35 P.S. §
      10231.102(4).     The MMA established a medical marijuana
      program to serve as a stopgap measure, “pending Federal
      approval of and access to medical marijuana through traditional
      medical and pharmaceutical avenues.” See id. The plain text of
      the MMA acknowledges the potential therapeutic value of medical
      marijuana, but it does not declare that marijuana has accepted
      medical use. See 35 P.S. § 10231.102(1), (3); Waddell, supra.
      Instead, the MMA intends to be “a temporary measure, pending
      Federal approval of and access to medical marijuana through
      traditional medical and pharmaceutical avenues.” See 35 P.S.
      § 10231.102(4). Therefore, the MMA and the CSA Schedule I
      classification of marijuana do not conflict on the ground of
      “currently accepted medical use.” Instead, the General Assembly
      allows for the use of medical marijuana under very specific
      guidelines which, when followed, will not lead to criminal
      punishment. See 35 P.S. § 10231.2101.

Id. at 1114. Likewise, applying rational basis scrutiny, we rejected Jezzi’s

Equal Protection challenge. Id. at 1115 (holding that because marijuana’s

Schedule I classification “is rationally related to the governmental objective of

public protection,” it does not violate the Equal Protection Clause).

                                      -9-
J-A05017-22

       We also addressed the ongoing classification of marijuana as a Schedule

I controlled substance for DUI purposes in Commonwealth v. Murray, No.

316 WDA 2020, 2020 WL 7861244 (Pa. Super. Dec. 31, 2020) (unpublished

memorandum). Murray, who was authorized under the MMA to procure and

use medical marijuana, claimed that the MMA preempted his prosecution

under Section 3802(d)(1)(i).        Id. at *3. The panel agreed that under the

MMA, “‘there is a legal distinction between marijuana and medical marijuana,’”

but concluded that medical marijuana was not at issue because Murray

illegally obtained and smoked marijuana before driving. Id. at *5; but cf.

Commonwealth v. Grimes, No. 980 MDA 2019, unpublished memorandum

at *6 (Pa. Super. Jan. 31, 2020) (finding sufficient evidence for Section

3802(d)(1)(i) and (iii) convictions despite citation to the MMA).

       Finally, after the parties’ submissions here, we decided the Section

3802(d)(1) case of Commonwealth v. Stone, 2022 PA Super 65, ___ A.3d

___, 2022 WL 1087372 (Apr. 12, 2022) (en banc). In Stone, we rejected a

proposed jury instruction that medical marijuana is not a Schedule I controlled

substance and that to convict Stone, the Commonwealth had to prove that

the THC and metabolites in his blood were from non-medical marijuana. Id.

at *4. Because marijuana, “which includes medical marijuana,” is a Schedule

I controlled substance, the jury instruction misstated the law. Id. at *7.8

____________________________________________

8 We declined to provide an advisory opinion for the Commonwealth’s final
issue, which was whether a medical marijuana card prevents a Section
3802(d)(1) conviction. Stone, ___ A.3d at ___, 2022 WL 1087372, at *8.

                                          - 10 -
J-A05017-22

   A. Arguments of the parties

      Dabney argues that his prescription for medical marijuana should

prohibit the Commonwealth from charging and prosecuting him under 75

Pa.C.S.A. § 3802(d)(1)(i) and (iii) because medical marijuana is not a

Schedule I controlled substance in Pennsylvania. Dabney’s Brief at 12–13,

21–23.    He urges that a contrary interpretation would render Section

3802(d)(1) in direct conflict with the MMA.     Id. at 13–15 (citing 35 P.S.

§§ 780-104, 10231.102, 10231.103, and 10231.2101).

      Dabney emphasizes our observation in Jezzi that “medical marijuana is

not listed in the CSA as a Schedule I substance, only marijuana is listed.” Id.

at 17 (quoting Jezzi, 208 A.3d at 1115). He distinguishes the outcomes of

Jezzi and Murray on the basis that the defendants in those cases did not

comply with the MMA, whereas there was no evidence considered by the

suppression court here to indicate Dabney’s noncompliance. Cf. Jezzi, 208

A.3d at 1114 (“[Jezzi, who grew marijuana plants prior to enactment of the

MMA,] did not meet any criteria under the MMA to merit its protection directly

or indirectly.”); Murray, No. 316 WDA 2020, at *11–12 (reiterating the trial

court’s findings that Murray had illegally obtained and smoked marijuana

before driving); see also Stone, ___ A.3d at ___, 2022 WL 1087372 at *1–

2 (summarizing that Stone did not have his medical marijuana card with him

yet had a bag of marijuana, and the Trooper smelled burnt marijuana, which

could reflect violations of 35 P.S. §§ 10231.303(b)(7) and 10231.304(b)(1)).

                                    - 11 -
J-A05017-22

      Presumably regarding the application of Section 3802(d)(1)(iii), Dabney

quotes our reasoning in Commonwealth v. Glenn, 233 A.3d 842, 846 (Pa.

Super. 2020), in which we stated, “If an individual has a medical prescription

for a controlled substance such as Fentanyl, it follows that the individual may

lawfully have metabolites produced by the controlled substance in their

bloodstream while their body is metabolizing the Fentanyl.” Id.

      The Commonwealth counters that the suppression court’s ruling was

correct. The Commonwealth mirrors the suppression court’s analysis, noting

that statutory and decisional law has not altered marijuana’s classification as

a Schedule I controlled substance. Commonwealth’s Brief at 11. It observes

that Jezzi did not reclassify medical marijuana or address the impact of the

MMA on the Vehicle Code. The Commonwealth notes that Glenn concerned a

Schedule II controlled substance and its metabolite, unlike the instant case.

Compare 75 Pa.C.S.A. § 3802(d)(1)(ii) (prohibiting driving with a Schedule

II controlled substance “which has not been medically prescribed for the

individual”), with id. § 3802(d)(1)(i) (containing no such exception).     The

Commonwealth quotes Judge Stabile’s concurrence in Commonwealth v.

Yeager, 2020 WL 6799113, No. 2036 MDA 2019, non-precedential concurring

memorandum at *7 (Pa. Super. Nov. 19, 2020) (likening medical marijuana

to alcohol, both of which can legally be consumed but cannot legally be above

certain levels in the blood of a person who drives). Absent an exception under

the Vehicle Code, the Commonwealth concludes that a medical marijuana card

does not prevent prosecution under Section 3802(d)(1)(i) or (iii).

                                    - 12 -
J-A05017-22

   B. Analysis

      After careful consideration, we find that medical marijuana remains a

Schedule I controlled substance for purposes of Section 3802(d)(1). Contrary

to Dabney’s argument, no conflict exists between the MMA and the Vehicle

Code. The Vehicle Code and the CSA render it illegal to drive with any amount

of a Schedule I controlled substance in one’s blood.            75 Pa.C.S.A.

§ 3802(d)(1)(i). Dabney attempts to argue that based on the MMA, medical

marijuana is not a Schedule I controlled substance. We are unpersuaded.

      As explained in Jezzi, the MMA did not remove marijuana from the list

of Schedule I controlled substances. Jezzi, 208 A.3d at 1115. There is no

need for “medical marijuana” to be listed as a Schedule I controlled substance

because medical marijuana is marijuana, specifically marijuana “for certified

medical use.”    35 P.S. § 10231.103.   All marijuana, medical or otherwise,

remains a Schedule I controlled substance in Pennsylvania. Stone, ___ A.3d

at ___, 2022 WL 1087372, at *7.

      Section 3802(d)(1)(i) prohibits driving with marijuana in one’s blood,

notwithstanding the MMA. The MMA takes precedence over the CSA related

to “[t]he growth, processing, manufacture, acquisition, transportation, sale,

dispensing, distribution, possession and consumption of medical marijuana

permitted under” the MMA. 35 P.S. § 10231.2101. Therefore, “compliance

with the MMA will not constitute a crime under the CSA.” Commonwealth

v. Barr, 266 A.3d 25, 41 (Pa. 2021) (quoting Commonwealth v. Barr, 240

A.3d 1263 (Pa. Super. 2020)). However, what Section 3802(d)(1) prohibits

                                    - 13 -
J-A05017-22

is not “growth, processing, manufacture, acquisition, transportation, sale,

dispensing, distribution, possession [or] consumption of medical marijuana”

but rather driving with a controlled substance in one’s blood. Yeager, supra,

at *7 (Stabile, J., concurring) (“Simply stated, it is illegal to smoke or vape

marijuana and drive.”).9 The MMA does not take precedence over laws not

specified in 35 P.S. § 10231.2101. See 35 P.S. § 10231.1309(1) (allowing

civil and criminal penalties for negligently undertaking tasks under the

influence of medical marijuana).10 As such, Dabney is not “facing a criminal

conviction for the legal use of his medical marijuana.” Dabney’s Brief at 19.

He was prosecuted for driving after such use. As in Jezzi and Stone, we

find that the MMA, CSA, and Vehicle Code can be read in harmony.

       Having found that Section 3802(d)(1)(i) applies to all marijuana, even

medical marijuana, we likewise conclude that Section 3802(d)(1)(iii) applies

to metabolites of all marijuana, including medical marijuana.            First,

subparagraph (iii) references subparagraph (i), which has no exception for

____________________________________________

9 See also Michael DeAngelo, Comment, Medical Marijuana and Driving Under
the Influence in Pennsylvania, 92 Temp. L. Rev. 225, 238 (2019) (“With the
passing of the MMA, the Pennsylvania state legislature did not amend the
[CSA] nor state DUI laws. Marijuana remains a Schedule I controlled
substance, and as such, is prosecutable under section 3802(d)(1) as a per se
offense when any amount of marijuana, or its metabolite, is found in a
person’s system. No showing of impairment is required.” (footnotes omitted)).
10Although not necessary to the disposition of this issue, legislative history
pre- and post-enactment of the MMA further supports our conclusion. S.B. 3,
Amend. A06066 (Pa. 2016) (rejected language warning about DUI of medical
marijuana); S.B. 167 (Pa. 2021) (proposed removal of DUI penalty for medical
marijuana use, referred to committee); H.B. 900 (Pa. 2021) (same).

                                          - 14 -
J-A05017-22

medical marijuana. Second, unlike in Glenn, 233 A.3d at 846, it is illegal to

drive with the active substance of marijuana in one’s blood. Therefore, it is

not absurd or unreasonable that it is also illegal to drive with a metabolite of

that substance in one’s blood.

       Because Dabney drove with marijuana in his blood, and because all

marijuana, including medical marijuana, remains a Schedule I controlled

substance for purposes not prohibited by the MMA, we hold that Dabney could

be charged and prosecuted under Section 3802(d)(1)(i) and (iii). Therefore,

we affirm the suppression court’s disposition of this issue.

       II.    Trooper Brandt Had Probable Cause to Arrest Dabney.

       Second, Dabney claims that the suppression court erred in concluding

that there was probable cause to arrest him for DUI and in failing to suppress

the blood draw that followed. Dabney’s Brief at 4. Dabney acknowledges the

legality of the initial traffic stop for speeding. Id. at 25. However, he argues

that Trooper Brandt began a new investigative detention when he asked about

the marijuana odor and asked Dabney to exit the vehicle.         Id. at 27–30.

Dabney stresses that the only additional basis to detain him at that moment

was the odor of raw marijuana. Therefore, he submits that Trooper Brandt’s

demand that he perform field sobriety tests amounted to an illegal detention

not supported by reasonable suspicion. Id. at 30–33.11
____________________________________________

11Dabney makes this new-investigative-detention argument for the first time
on appeal. Although this would be a basis for us to find waiver, see Pa.R.A.P.
(Footnote Continued Next Page)

                                          - 15 -
J-A05017-22

       We find no merit to this issue. Our Supreme Court has held that because

of the MMA, “the odor of marijuana alone does not amount to probable cause

to conduct a warrantless search of a vehicle but, rather, may be considered

as a factor in examining the totality of the circumstances.” Barr, 266 A.3d at

44.    Assuming arguendo that Barr also applies to a determination of

reasonable suspicion for an investigative detention, we find that Trooper

Brandt could consider the odor as well as the other factors from the initial

stop. “[I]nformation obtained by a police officer during a lawful initial traffic

stop may be used to justify re-engagement with the driver after the police

officer indicates the driver is free to go.” In the Interest of A.A., 195 A.3d

896, 898 (Pa. 2018), abrogated on “plain smell” grounds by Barr, 266 A.3d

at 41. Here, the odor of raw marijuana is but one factor that Trooper Brandt

could consider in addition to the factors supporting his initial traffic stop, which

Dabney acknowledges was legal. Dabney’s Brief at 25. Therefore, Trooper

Brandt had reasonable suspicion to detain Dabney to conduct field sobriety

tests. Likewise, we discern no error of law in the suppression court’s resulting

conclusion that Trooper Brandt had probable cause to arrest Dabney under

suspicion of DUI following the failed field sobriety tests. See Commonwealth

v. Salter, 121 A.3d 987, 996–98 (Pa. Super. 2015) (finding probable cause

to arrest under suspicion of DUI based on field sobriety tests).

____________________________________________

302, we will address the merits because the Commonwealth has not argued
that Dabney waived this issue. Cf. Commonwealth v. Wolfel, 233 A.3d
784, 790 (Pa. 2020) (reversing this Court’s sua sponte finding of waiver).

                                          - 16 -
J-A05017-22

     Judgment of sentence affirmed.

Judgment Entered.

Joseph D. Seletyn, Esq.
Prothonotary

Date: 5/5/2022

                                 - 17 -